Pembrolizumab-induced toxic epidermal necrolysis: A rare cause of severe adverse drug reaction

Indian J Dermatol Venereol Leprol. 2023 Jul-Aug;89(4):589-591. doi: 10.25259/IJDVL_612_2022.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Humans
  • Stevens-Johnson Syndrome* / diagnosis
  • Stevens-Johnson Syndrome* / etiology

Substances

  • pembrolizumab
  • Antibodies, Monoclonal, Humanized